HRP20161792T1 - Sojevi bifidobacterium bifiduma za primjenu u gastrointestinalnim bolestima - Google Patents
Sojevi bifidobacterium bifiduma za primjenu u gastrointestinalnim bolestima Download PDFInfo
- Publication number
- HRP20161792T1 HRP20161792T1 HRP20161792TT HRP20161792T HRP20161792T1 HR P20161792 T1 HRP20161792 T1 HR P20161792T1 HR P20161792T T HRP20161792T T HR P20161792TT HR P20161792 T HRP20161792 T HR P20161792T HR P20161792 T1 HRP20161792 T1 HR P20161792T1
- Authority
- HR
- Croatia
- Prior art keywords
- probiotic formulation
- powder
- food product
- tablet
- strain
- Prior art date
Links
- 241000186016 Bifidobacterium bifidum Species 0.000 title claims 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 title claims 2
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 claims 12
- 238000009472 formulation Methods 0.000 claims 11
- 239000006041 probiotic Substances 0.000 claims 11
- 235000018291 probiotics Nutrition 0.000 claims 11
- 230000000529 probiotic effect Effects 0.000 claims 10
- 235000013305 food Nutrition 0.000 claims 6
- 239000000843 powder Substances 0.000 claims 6
- 239000002775 capsule Substances 0.000 claims 5
- 150000001720 carbohydrates Chemical class 0.000 claims 3
- 235000014633 carbohydrates Nutrition 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 235000013343 vitamin Nutrition 0.000 claims 3
- 239000011782 vitamin Substances 0.000 claims 3
- 229940088594 vitamin Drugs 0.000 claims 3
- 229930003231 vitamin Natural products 0.000 claims 3
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- 229920001202 Inulin Polymers 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 2
- 229940029339 inulin Drugs 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000010755 mineral Nutrition 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 235000013618 yogurt Nutrition 0.000 claims 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 1
- 208000004998 Abdominal Pain Diseases 0.000 claims 1
- 206010000060 Abdominal distension Diseases 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 241000193163 Clostridioides difficile Species 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 208000002389 Pouchitis Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 1
- 208000024330 bloating Diseases 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 239000008121 dextrose Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 claims 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims 1
- 229940107187 fructooligosaccharide Drugs 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 239000002366 mineral element Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 235000021262 sour milk Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 239000011573 trace mineral Substances 0.000 claims 1
- 235000013619 trace mineral Nutrition 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11000744.0A EP2481299B1 (en) | 2011-01-31 | 2011-01-31 | Bifidobacterium bifidum strains for application in gastrointestinal diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161792T1 true HRP20161792T1 (hr) | 2017-03-10 |
Family
ID=43901563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161792TT HRP20161792T1 (hr) | 2011-01-31 | 2016-12-28 | Sojevi bifidobacterium bifiduma za primjenu u gastrointestinalnim bolestima |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9408879B2 (enExample) |
| EP (1) | EP2481299B1 (enExample) |
| JP (1) | JP5956467B2 (enExample) |
| CN (1) | CN103476273A (enExample) |
| AU (1) | AU2012213576B2 (enExample) |
| BR (1) | BR112013019258B1 (enExample) |
| CA (1) | CA2825980C (enExample) |
| DK (1) | DK2481299T3 (enExample) |
| ES (1) | ES2610908T3 (enExample) |
| HR (1) | HRP20161792T1 (enExample) |
| HU (1) | HUE033189T2 (enExample) |
| PL (1) | PL2481299T3 (enExample) |
| PT (1) | PT2481299T (enExample) |
| RU (1) | RU2603285C2 (enExample) |
| WO (1) | WO2012104226A1 (enExample) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| CN103266076B (zh) * | 2013-06-04 | 2014-10-29 | 神舟太空产品高科技成果推广中心集团有限公司 | 太空诱变高效两歧双歧杆菌、其应用及其胶囊制剂的制备方法 |
| CN104546945A (zh) * | 2014-09-30 | 2015-04-29 | 深圳华大基因科技有限公司 | 两歧双歧杆菌在治疗或预防类风湿性关节炎或其相关疾病中的用途 |
| PT3065748T (pt) | 2014-12-23 | 2018-02-28 | 4D Pharma Res Ltd | Uma estirpe de bacteroides thetaiotaomicron e o seu uso na redução da inflamação |
| BR112017013274A2 (pt) | 2014-12-23 | 2018-02-06 | 4D Pharma Research Limited | polipeptídeo e imunomodulação |
| JP2018507872A (ja) * | 2015-03-09 | 2018-03-22 | バイオイミュナイザー・ソチエタ・ア・ガランツィア・リミタータＢｉｏｉｍｍｕｎｉｚｅｒ ＳＡＧＬ | ビフィズス菌およびプロバイオティクスから単離された細胞壁をともなう抗酸化剤の組み合わせを含むアンチエイジング組成物 |
| SMT201900588T1 (it) | 2015-06-15 | 2019-11-13 | 4D Pharma Res Limited | Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni |
| PL3307288T3 (pl) | 2015-06-15 | 2019-12-31 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
| PT3360559T (pt) | 2015-06-15 | 2020-01-06 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| JP6637725B2 (ja) * | 2015-10-28 | 2020-01-29 | ビオフェルミン製薬株式会社 | ウイルス感染症の予防及び／又は治療剤 |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| HUE036362T2 (hu) | 2015-11-20 | 2018-07-30 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| PL3313423T3 (pl) | 2016-03-04 | 2019-09-30 | 4D Pharma Plc | Kompozycje zawierające szczepy bakteryjne blautia do leczenia nadwrażliwości trzewnej |
| CA3020389A1 (en) * | 2016-04-14 | 2017-10-19 | Dupont Nutrition Biosciences Aps | Bifidobacteria for increasing lean body mass |
| TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商４Ｄ製藥有限公司 | 包含細菌菌株之組合物 |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| CN106579414A (zh) * | 2016-12-26 | 2017-04-26 | 北京康比特体育科技股份有限公司 | 一种缓解运动性腹泻的组合物 |
| CN106834187B (zh) * | 2017-03-06 | 2020-08-25 | 江南大学 | 一种两歧双歧杆菌及其用途 |
| WO2018165563A1 (en) * | 2017-03-09 | 2018-09-13 | The Clorox Company | Probiotic capsule and methods of preparing the same |
| JP2018177703A (ja) * | 2017-04-14 | 2018-11-15 | 株式会社明治 | Ｔｏｌｌ様受容体２活性化用組成物 |
| JP7212945B2 (ja) | 2017-05-22 | 2023-01-26 | フォーディー ファーマ リサーチ リミテッド | 細菌株を含む組成物 |
| MA41708A (fr) | 2017-05-24 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| HUE059249T2 (hu) | 2017-06-14 | 2022-11-28 | 4D Pharma Res Limited | Baktériumtörzseket tartalmazó készítmények |
| PT3638271T (pt) | 2017-06-14 | 2021-01-05 | 4D Pharma Res Ltd | Composições contendo estirpes bacterianas |
| AU2018285445B2 (en) | 2017-06-14 | 2020-03-26 | Cj Bioscience, Inc. | Compositions comprising bacterial strains |
| KR102760825B1 (ko) * | 2018-01-29 | 2025-02-03 | 프리시젼바이오틱스 그룹 리미티드 | 과민성 대장 증후군의 예방 및 치료를 위한 조합 생성물 |
| KR102023700B1 (ko) * | 2018-01-31 | 2019-09-20 | 주식회사 비피도 | 비피도박테리움을 함유한 류마티스관절염 개선용, 치료용 또는 예방용 조성물 |
| AU2019289987A1 (en) * | 2018-06-22 | 2020-12-24 | Synformulas Gmbh | Non-viable Bifidobacterium bifidum bacteria and uses thereof |
| BR112021007249A2 (pt) * | 2019-01-16 | 2021-08-10 | N.V. Nutricia | composições nutricionais |
| IT201900011193A1 (it) * | 2019-07-08 | 2021-01-08 | Sofar Spa | Ceppo di batteri Bifidobacterium bifidum, sue composizioni e relativi usi |
| WO2021044376A1 (en) * | 2019-09-05 | 2021-03-11 | White Dog Labs, Inc. | Mixotrophic probiotic compositions and uses thereof in the treatment of bloating |
| IT201900016811A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali |
| CN118924795A (zh) * | 2019-11-29 | 2024-11-12 | 内蒙古伊利实业集团股份有限公司 | 乳双歧杆菌bl-99提升肠道细菌感染抗性和肠道免疫力的应用 |
| CN111110704B (zh) * | 2020-02-14 | 2023-03-28 | 上海城建职业学院 | 一种益生菌菌剂、滴剂及其制备方法和应用 |
| CN111743998A (zh) * | 2020-06-04 | 2020-10-09 | 中通美雅生命健康(深圳)有限公司 | 用于辅助治疗肠炎组合物及其制备方法 |
| RU2735717C1 (ru) * | 2020-06-15 | 2020-11-06 | Общество с ограниченной ответственностью "АВАН" | Штамм Bifidobacterium bifidum, используемый в качестве пробиотика |
| JP2023542547A (ja) * | 2020-09-23 | 2023-10-10 | ピービーエルバイオラブ | 新規乳酸菌およびその用途 |
| CN113943682B (zh) * | 2020-11-12 | 2023-07-04 | 江南大学 | 缓解便秘的长双歧杆菌长亚种及其制备的发酵食品与益生菌制剂 |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| US20240000808A1 (en) * | 2020-11-16 | 2024-01-04 | Orcosa Inc. | Improved use of cannabinoids in the treatment of alzheimer's disease |
| CN112980734B (zh) * | 2021-03-24 | 2022-07-22 | 江南大学 | 一株缓解便秘并调节肠道菌群紊乱的两歧双歧杆菌及其应用 |
| CN113025526B (zh) * | 2021-03-24 | 2022-09-27 | 江南大学 | 一株减少结肠病理损伤且具有缓解便秘作用的两歧双歧杆菌 |
| CN113234619B (zh) * | 2021-04-10 | 2022-07-05 | 江南大学 | 一株两歧双歧杆菌及其在缓解肠道损伤中的应用 |
| CN118291322A (zh) * | 2022-07-13 | 2024-07-05 | 四川大学 | 一株婴幼儿肠道来源的两歧双歧杆菌 |
| CN116286439A (zh) * | 2022-07-13 | 2023-06-23 | 四川大学 | 一株婴幼儿肠道来源的两歧双歧杆菌及应用 |
| CN115838662A (zh) * | 2022-11-02 | 2023-03-24 | 江南大学 | 一株具有缓解克罗恩病潜力的两歧双歧杆菌 |
| WO2024193633A1 (zh) * | 2023-03-21 | 2024-09-26 | 四川厌氧生物科技有限责任公司 | 一种益生菌及其应用 |
| CN118044616A (zh) * | 2023-09-05 | 2024-05-17 | 厦门大学 | 一种合生元及其用途 |
| WO2025059424A1 (en) * | 2023-09-15 | 2025-03-20 | Biohm Health Inc. | Pro-biotic compositions and methods for treatment of stress |
| CN118879582B (zh) * | 2024-09-19 | 2025-03-25 | 微康益生菌(苏州)股份有限公司 | 一种细胞完整、分散均匀、稳定性强的后生元制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID29150A (id) | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| RU2152993C1 (ru) * | 1999-11-30 | 2000-07-20 | Государственный научный центр РФ Институт медико-биологических проблем | Штамм bifidobacterium bifidum вкпм ас-1578, используемый для приготовления бактериальных препаратов и продуктов питания |
| RU2184146C1 (ru) * | 2001-01-29 | 2002-06-27 | Закрытое акционерное общество "Партнер" | Штамм bifidobacterium bifidum 45 вкпм ас-1621, используемый для приготовления бактериальных препаратов и продуктов питания |
| DE602004006133T3 (de) * | 2003-06-30 | 2014-12-24 | Clasado Inc. | Neue galactooligosaccharidzusammensetzung und herstellung davon |
| PL1673100T3 (pl) * | 2004-08-05 | 2008-01-31 | Anidral Srl | Szczepy bakterii Bifidobacterium wytwarzające kwas foliowy, preparaty i ich zastosowanie |
| AR053805A1 (es) * | 2005-05-31 | 2007-05-23 | Iams Company | Bifidobacterias probioticas para felinos |
| CN100490826C (zh) * | 2005-07-05 | 2009-05-27 | 广州市微生物研究所 | 多联活性双歧杆菌产品的制备方法 |
| JP4881304B2 (ja) * | 2005-07-21 | 2012-02-22 | 株式会社ヤクルト本社 | 新規ビフィドバクテリウム属細菌及びその利用 |
| US9084434B2 (en) * | 2006-09-27 | 2015-07-21 | Little Calumet Holdings Llc | Probiotic oral dosage forms |
| CN101636173A (zh) * | 2007-03-27 | 2010-01-27 | 宝洁公司 | 施用益生菌剂的方法及试剂盒 |
| DK2270133T3 (en) * | 2008-04-22 | 2015-09-07 | Corporación Alimentaria Peñasanta Capsa | Method of obtaining a new strain of Bifidobacterium bidifum with effect against infection with Helicobacter pylori |
| RU2010143460A (ru) * | 2008-05-01 | 2012-06-10 | Дзе Проктер Энд Гэмбл Компани (US) | Способы и наборы для терапии восстановительных состояний кишечника |
| WO2009151329A1 (en) * | 2008-06-13 | 2009-12-17 | N.V. Nutricia | Nutrition for prevention of infections |
-
2011
- 2011-01-31 DK DK11000744.0T patent/DK2481299T3/en active
- 2011-01-31 PL PL11000744T patent/PL2481299T3/pl unknown
- 2011-01-31 HU HUE11000744A patent/HUE033189T2/en unknown
- 2011-01-31 EP EP11000744.0A patent/EP2481299B1/en active Active
- 2011-01-31 ES ES11000744.0T patent/ES2610908T3/es active Active
- 2011-01-31 PT PT110007440T patent/PT2481299T/pt unknown
-
2012
- 2012-01-27 AU AU2012213576A patent/AU2012213576B2/en active Active
- 2012-01-27 BR BR112013019258-5A patent/BR112013019258B1/pt active IP Right Grant
- 2012-01-27 JP JP2013550895A patent/JP5956467B2/ja active Active
- 2012-01-27 RU RU2013137404/10A patent/RU2603285C2/ru active
- 2012-01-27 WO PCT/EP2012/051369 patent/WO2012104226A1/en not_active Ceased
- 2012-01-27 CN CN2012800125218A patent/CN103476273A/zh active Pending
- 2012-01-27 CA CA2825980A patent/CA2825980C/en active Active
- 2012-01-27 US US13/982,932 patent/US9408879B2/en active Active
-
2016
- 2016-12-28 HR HRP20161792TT patent/HRP20161792T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2481299T (pt) | 2017-03-08 |
| EP2481299A1 (en) | 2012-08-01 |
| EP2481299B1 (en) | 2016-12-07 |
| JP5956467B2 (ja) | 2016-07-27 |
| HUE033189T2 (en) | 2017-11-28 |
| CA2825980C (en) | 2017-10-24 |
| NZ613544A (en) | 2014-10-31 |
| PL2481299T3 (pl) | 2017-09-29 |
| WO2012104226A1 (en) | 2012-08-09 |
| BR112013019258A8 (pt) | 2017-09-19 |
| BR112013019258A2 (pt) | 2016-10-11 |
| ES2610908T3 (es) | 2017-05-04 |
| CN103476273A (zh) | 2013-12-25 |
| US20140056852A1 (en) | 2014-02-27 |
| JP2014505065A (ja) | 2014-02-27 |
| RU2603285C2 (ru) | 2016-11-27 |
| US9408879B2 (en) | 2016-08-09 |
| CA2825980A1 (en) | 2012-08-09 |
| BR112013019258B1 (pt) | 2021-09-08 |
| AU2012213576B2 (en) | 2015-07-23 |
| DK2481299T3 (en) | 2017-02-06 |
| RU2013137404A (ru) | 2015-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20161792T1 (hr) | Sojevi bifidobacterium bifiduma za primjenu u gastrointestinalnim bolestima | |
| JP2014505065A5 (enExample) | ||
| Bertazzoni et al. | Probiotics and clinical effects: is the number what counts? | |
| KR102606971B1 (ko) | 생애 초기에 미생물총 불균형을 회복하기 위한 l. 루테리의 용도 | |
| EP2700412A1 (en) | PROBIOTICS, SECRETORY IgA AND INFLAMMATION | |
| JP2018536427A5 (enExample) | ||
| CN110393728A (zh) | 乳酸杆菌属、其医药组合物及可食用组合物于治疗、预防或改善骨质疾病的用途 | |
| RU2018119287A (ru) | Бифидобактерии лонгум для лечения ожирения и связанных с ним метаболических нарушений | |
| ES2604136T3 (es) | Composición que comprende proteínas lácteas termolábiles y proceso para la preparación de la misma | |
| JPWO2017110988A1 (ja) | ゲル状食品組成物 | |
| ES2763350B2 (es) | Cepa de christensenella minuta y uso de la misma | |
| CN104207146A (zh) | 呼吸系统疾病全营养配方食品 | |
| CN116634889A (zh) | 通过益生菌菌株改善蛋白质消化和氨基酸生物利用度 | |
| CN102088981B (zh) | 帮助唾液分泌的唾液酸 | |
| CN104223057A (zh) | 肝病全营养配方食品 | |
| CN104161263B (zh) | 儿童全营养配方食品 | |
| CN105029393A (zh) | 儿童医学配方食品 | |
| CN104256633A (zh) | 妇女延更调理全营养配方食品 | |
| MX2010012254A (es) | Acido sialico para apoyar el sistema inmunologico en la vejez. | |
| CN108618140A (zh) | 孕妇产前调理医学配方食品 | |
| CN104839685A (zh) | 创伤感染手术及其它应急状态医学配方食品 | |
| Chauhan et al. | Probiotic, prebiotic and synbiotics in the prevention of lifestyle disorders | |
| CN111201026B (zh) | 具有癌性恶病质抑制作用的发酵乳和多糖类 | |
| TWI745454B (zh) | 抑制腸道內乳桿菌屬乳酸菌減少用之組成物 | |
| US20250352588A1 (en) | Effect of a probiotic composition on vaginal lactobacillus species |